MICRO THERAPEUTICS, INC. DBA EV3 PIPELINE VANTAGE WITH SHIELD TECHNOLOGY; INTRACRANIAL ANEURYSM FLOW DIVERTER
|
Back to Search Results |
|
Model Number PED3-027-500-20 |
Device Problems
Positioning Failure (1158); Unintended Movement (3026)
|
Patient Problem
Insufficient Information (4580)
|
Event Date 11/30/2021 |
Event Type
Death
|
Manufacturer Narrative
|
Medtronic is submitting this report to comply with fda reporting regulations under 21 cfr parts 4 and 803.This report is based upon information obtained by medtronic, which the company may not have been able to fully investigate or verify prior to the date the report was required by the fda.Medtronic has made reasonable efforts to obtain more complete information and has provided as much relevant information as is available to the company as of the submission date of this report.This report does not constitute an admission or a conclusion by fda, medtronic, or its employees that the device, medtronic, or its employee caused or contributed to the event described in the report.In particular, this report does not constitute an admission by anyone that the product described in this report has any ¿defects¿ or has ¿malfunctioned¿.These words are included in the fda 3500a form and are fixed items for selection created by the fda to categorize the type of event solely for the purpose of regulatory reporting.Medtronic objects to the use of these words and others like them because of the lack of definition and the connotations implied by these terms.This statement should be included with any information or report disclosed to the public under the freedom of information act.Any required fields that are unpopulated are blank because the information is currently unknown or unavailable.A good faith effort will be made to obtain the applicable information relevant to the report.If information is provided in the future, a supplemental report will be issued.
|
|
Event Description
|
Medtronic received a report that the pipeline vantage had movement during deployment, and the patient unexpectedly passed away 3 days after the procedure.The patient was undergoing treatment for an unruptured, saccular aneurysm located in the ophthalmic segment below the posterior communicating artery.The max diameter was 24mm, and the neck diameter was 10+mm.The patient's vessel tortuosity was normal.The landing zone was 5mm distal and 4.5mm proximal. dual antiplatelet treatment was administered.It was reported that distal end of the first pipeline fell back during deployment and the physician could not track the system back to the intended landing zone, so the entire system was removed from the patient.A replacement pipeline was implanted without issue. the patient was reported to be well after the procedure.However, they passed away on (b)(6) 2021.A head ct could not be performed following the death of the patient, so the cause of death was unknown.Angiographic results post procedure were said to be excellent with contrast stasis with the coils in place.The devices were prepared according to the instructions for use (ifu).Ancillary devices include multiple penumbra pc400 coils.
|
|
Manufacturer Narrative
|
Medtronic is submitting this report to comply with fda reporting regulations under 21 cfr parts 4 and 803.This report is based upon information obtained by medtronic, which the company may not have been able to fully investigate or verify prior to the date the report was required by the fda.Medtronic has made reasonable efforts to obtain more complete information and has provided as much relevant information as is available to the company as of the submission date of this report.This report does not constitute an admission or a conclusion by fda, medtronic, or its employees that the device, medtronic, or its employee caused or contributed to the event described in the report.In particular, this report does not constitute an admission by anyone that the product described in this report has any ¿defects¿ or has ¿malfunctioned¿.These words are included in the fda 3500a form and are fixed items for selection created by the fda to categorize the type of event solely for the purpose of regulatory reporting.Medtronic objects to the use of these words and others like them because of the lack of definition and the connotations implied by these terms.This statement should be included with any information or report disclosed to the public under the freedom of information act.Any required fields that are unpopulated are blank because the information is currently unknown or unavailable.A good faith effort will be made to obtain the applicable information relevant to the report.If information is provided in the future, a supplemental report will be issued.
|
|
Event Description
|
The physician doesn¿t believe it was the fd + coil treatment.He has treated many aneurysm with this combination, this is the first time a patient has died.We will have to wait for the report.The cause of death remains unknown.No friction, everything was normal.The deployment technique employed was a standard push and pull technique.Whereby the delivery wire was pushed while the microcatheter was withdrawn to reduce tension.
|
|
Event Description
|
Additional information received reported that the physician though the first pipeline was anchored distally as it appeared to have wall apposition under fluoroscopy.However, that was evidenced to no be the case as movement occurred.Cause of death has not been confirmed as there is a several months wait list for a neuropathologist to be available to perform post-mortem.
|
|
Manufacturer Narrative
|
B5.Updated with additional information received.Medtronic is submitting this report to comply with fda reporting regulations under 21 cfr parts 4 and 803.This report is based upon information obtained by medtronic, which the company may not have been able to fully investigate or verify prior to the date the report was required by the fda.Medtronic has made reasonable efforts to obtain more complete information and has provided as much relevant information as is available to the company as of the submission date of this report.This report does not constitute an admission or a conclusion by fda, medtronic, or its employees that the device, medtronic, or its employee caused or contributed to the event described in the report.In particular, this report does not constitute an admission by anyone that the product described in this report has any ¿defects¿ or has ¿malfunctioned¿.These words are included in the fda 3500a form and are fixed items for selection created by the fda to categorize the type of event solely for the purpose of regulatory reporting.Medtronic objects to the use of these words and others like them because of the lack of definition and the connotations implied by these terms.This statement should be included with any information or report disclosed to the public under the freedom of information act.Any required fields that are unpopulated are blank because the information is currently unknown or unavailable.A good faith effort will be made to obtain the applicable information relevant to the report.If information is provided in the future, a supplemental report will be issued.
|
|
Search Alerts/Recalls
|
|
|